期刊
ACTA MEDICA MEDITERRANEA
卷 34, 期 1, 页码 153-158出版社
CARBONE EDITORE
DOI: 10.19193/0393-6384_2018_1_25
关键词
hypertension; type 2 diabetes; drug; SBP; DBP
资金
- National High-tech R&D Program (863 Program) of China [SS2015AA020109]
- Science and Technology Planning Project of Guangdong Province [2015B010129012]
- National Natural Science Foundation of China [31501065]
Background: Hypertension remains a major global public health problem. The objective of this study was to evaluate the appropriateness of drug usage in Chinese hypertensive patients. Methodology: Patients data with drug usage were collected from Shenzhen in China. Student' t test was used to compare the diastolic blood pressure (DBP) and systolic blood pressure (SBP) differences. Results: A total of 58,971 hypertensive patients and 12,732 hypertensive patients with type 2 diabetes were studied. The abnormal DBP (mean: 81 mmHg) and SBP (mean: above 130 mmHg) observed in two groups indicated both populations were correctly diagnosed with hypertension. Those hypertensive patients with type 2 diabetes got significant higher SBP (mean: 133 mmHg), suggesting they were more severe. After a period of at least 3 years follow up investigations, the SBP of patients with only hypertension dropped to a mean value of 129 mmHg. Hypertensive patients with type 2 diabetes also showed significant SBP decreasing changes, with the mean of SBP around 130 mmHg. The DBP of two groups decreased to the normal range after 3 years (mean: around 79 mmHg). Significance: These results supported the reasonability of current drug usage and had extensive applicability for other hypertensive patients' treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据